These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 22445654)

  • 21. CD160 isoforms and regulation of CD4 and CD8 T-cell responses.
    El-Far M; Pellerin C; Pilote L; Fortin JF; Lessard IA; Peretz Y; Wardrop E; Salois P; Bethell RC; Cordingley MG; Kukolj G
    J Transl Med; 2014 Sep; 12():217. PubMed ID: 25179432
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A herpesvirus entry mediator mutein with selective agonist action for the inhibitory receptor B and T lymphocyte attenuator.
    Šedý JR; Balmert MO; Ware BC; Smith W; Nemčovičova I; Norris PS; Miller BR; Aivazian D; Ware CF
    J Biol Chem; 2017 Dec; 292(51):21060-21070. PubMed ID: 29061848
    [TBL] [Abstract][Full Text] [Related]  

  • 23. BTLA inhibition has a dominant role in the
    Battin C; Leitner J; Waidhofer-Söllner P; Grabmeier-Pfistershammer K; Olive D; Steinberger P
    Front Immunol; 2022; 13():956694. PubMed ID: 36081508
    [TBL] [Abstract][Full Text] [Related]  

  • 24. B and T lymphocyte attenuator regulates T cell activation through interaction with herpesvirus entry mediator.
    Sedy JR; Gavrieli M; Potter KG; Hurchla MA; Lindsley RC; Hildner K; Scheu S; Pfeffer K; Ware CF; Murphy TL; Murphy KM
    Nat Immunol; 2005 Jan; 6(1):90-8. PubMed ID: 15568026
    [TBL] [Abstract][Full Text] [Related]  

  • 25. HVEM structures and mutants reveal distinct functions of binding to LIGHT and BTLA/CD160.
    Liu W; Chou TF; Garrett-Thomson SC; Seo GY; Fedorov E; Ramagopal UA; Bonanno JB; Wang Q; Kim K; Garforth SJ; Kakugawa K; Cheroutre H; Kronenberg M; Almo SC
    J Exp Med; 2021 Dec; 218(12):. PubMed ID: 34709351
    [TBL] [Abstract][Full Text] [Related]  

  • 26. T cell intrinsic heterodimeric complexes between HVEM and BTLA determine receptivity to the surrounding microenvironment.
    Cheung TC; Oborne LM; Steinberg MW; Macauley MG; Fukuyama S; Sanjo H; D'Souza C; Norris PS; Pfeffer K; Murphy KM; Kronenberg M; Spear PG; Ware CF
    J Immunol; 2009 Dec; 183(11):7286-96. PubMed ID: 19915044
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Targeting lymphocyte activation through the lymphotoxin and LIGHT pathways.
    Ware CF
    Immunol Rev; 2008 Jun; 223():186-201. PubMed ID: 18613837
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Characterization of herpes virus entry mediator as a factor linked to obesity.
    Bassols J; Moreno JM; Ortega F; Ricart W; Fernandez-Real JM
    Obesity (Silver Spring); 2010 Feb; 18(2):239-46. PubMed ID: 19680232
    [TBL] [Abstract][Full Text] [Related]  

  • 29. BTLA and HVEM cross talk regulates inhibition and costimulation.
    Gavrieli M; Sedy J; Nelson CA; Murphy KM
    Adv Immunol; 2006; 92():157-85. PubMed ID: 17145304
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evolutionarily divergent herpesviruses modulate T cell activation by targeting the herpesvirus entry mediator cosignaling pathway.
    Cheung TC; Humphreys IR; Potter KG; Norris PS; Shumway HM; Tran BR; Patterson G; Jean-Jacques R; Yoon M; Spear PG; Murphy KM; Lurain NS; Benedict CA; Ware CF
    Proc Natl Acad Sci U S A; 2005 Sep; 102(37):13218-23. PubMed ID: 16131544
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Interfering with coinhibitory molecules: BTLA/HVEM as new targets to enhance anti-tumor immunity.
    Pasero C; Olive D
    Immunol Lett; 2013 Mar; 151(1-2):71-5. PubMed ID: 23439006
    [TBL] [Abstract][Full Text] [Related]  

  • 32. HVEM signalling at mucosal barriers provides host defence against pathogenic bacteria.
    Shui JW; Larange A; Kim G; Vela JL; Zahner S; Cheroutre H; Kronenberg M
    Nature; 2012 Aug; 488(7410):222-5. PubMed ID: 22801499
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Potentiating vaccine immunogenicity by manipulating the HVEM/BTLA pathway and other co-stimulatory and co-inhibitory signals of the immune system.
    Lasaro MO; Ertl HC
    Hum Vaccin; 2009; 5(1):6-14. PubMed ID: 18927514
    [TBL] [Abstract][Full Text] [Related]  

  • 34. HVEM network signaling in cancer.
    Šedý JR; Ramezani-Rad P
    Adv Cancer Res; 2019; 142():145-186. PubMed ID: 30885361
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Targeting the LIGHT-HVEM pathway.
    Ware CF
    Adv Exp Med Biol; 2009; 647():146-55. PubMed ID: 19760072
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Soluble Fc-Disabled Herpes Virus Entry Mediator Augments Activation and Cytotoxicity of NK Cells by Promoting Cross-Talk between NK Cells and Monocytes.
    Meng Q; Zaidi AK; Sedy J; Bensussan A; Popkin DL
    J Immunol; 2019 Apr; 202(7):2057-2068. PubMed ID: 30770415
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Anti-HVEM mAb therapy improves antitumoral immunity both in vitro and in vivo, in a novel transgenic mouse model expressing human HVEM and BTLA molecules challenged with HVEM expressing tumors.
    Demerlé C; Gorvel L; Mello M; Pastor S; Degos C; Zarubica A; Angelis F; Fiore F; Nunes JA; Malissen B; Greillier L; Guittard G; Luche H; Barlesi F; Olive D
    J Immunother Cancer; 2023 May; 11(5):. PubMed ID: 37230538
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The evolving crosstalk between co-stimulatory and co-inhibitory receptors: HVEM-BTLA.
    Croft M
    Trends Immunol; 2005 Jun; 26(6):292-4. PubMed ID: 15922943
    [TBL] [Abstract][Full Text] [Related]  

  • 39. HVEM, a cosignaling molecular switch, and its interactions with BTLA, CD160 and LIGHT.
    Rodriguez-Barbosa JI; Schneider P; Weigert A; Lee KM; Kim TJ; Perez-Simon JA; Del Rio ML
    Cell Mol Immunol; 2019 Jul; 16(7):679-682. PubMed ID: 31160757
    [No Abstract]   [Full Text] [Related]  

  • 40. Regulating the mucosal immune system: the contrasting roles of LIGHT, HVEM, and their various partners.
    Steinberg MW; Shui JW; Ware CF; Kronenberg M
    Semin Immunopathol; 2009 Jul; 31(2):207-21. PubMed ID: 19495760
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.